FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059199034> ?p ?o ?g. }

• W2059199034 endingPage "e5182" @default.
• W2059199034 startingPage "e5182" @default.
• W2059199034 abstract "To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.Systematic review and indirect comparison.Medline (1996-September 2011), Embase (1996-September 2011), and the Cochrane Central Register of Controlled Trials (Issue 4, 2011).Randomised trials evaluating ranibizumab or bevacizumab in diabetic macular oedema with a common comparator and sufficient methodological similarity to be included within an indirect comparison were eligible for inclusion.The primary outcome was the proportion of patients with an improvement in best corrected visual acuity of more than two lines on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Secondary outcomes included mean changes in best corrected visual acuity and in central macular thickness, and adverse events. Best corrected visual acuity was converted to logMAR units, a linear scale of visual acuity with positive values representing increasing visual loss. Indirect comparisons were done using Bayesian methods to estimate relative treatment effects of bevacizumab and ranibizumab.Five randomised controlled trials with follow-up of 6-12 months and a common comparator (multiple laser treatment) were sufficiently similar to be included in the indirect comparison. Generally studies were small, resulting in wide credible intervals. The proportions of patients with an improvement in best corrected visual acuity of >2 lines were 21/77 participants (27%) for bevacizumab and 60/152 participants (39%) for ranibizumab (odds ratio 0.95 (95% credible interval 0.23 to 4.32)). The wide credible intervals cannot exclude a greater improvement, or worse outcome, for either drug. The mean change in best corrected visual acuity non-significantly favoured bevacizumab (treatment effect -0.08 logMAR units (-0.19 to 0.04)). The difference in mean change in central macular thickness was not statistically significant between ranibizumab and bevacizumab (treatment effect -6.9 μm (-88.5 to 65.4)).Results suggest no difference in effectiveness between bevacizumab and ranibizumab, but the wide credible intervals cannot exclude the possibility that either drug might be superior. Sufficiently powered, direct head to head trials are needed." @default.
• W2059199034 created "2016-06-24" @default.
• W2059199034 creator A5011208350 @default.
• W2059199034 creator A5058932170 @default.
• W2059199034 creator A5068981280 @default.
• W2059199034 creator A5070808034 @default.
• W2059199034 creator A5084642149 @default.
• W2059199034 date "2012-08-13" @default.
• W2059199034 modified "2023-10-16" @default.
• W2059199034 title "The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review" @default.
• W2059199034 cites W1154061703 @default.
• W2059199034 cites W1481978003 @default.
• W2059199034 cites W1505156782 @default.
• W2059199034 cites W1505979368 @default.
• W2059199034 cites W1517555081 @default.
• W2059199034 cites W1559170621 @default.
• W2059199034 cites W169363417 @default.
• W2059199034 cites W1968320087 @default.
• W2059199034 cites W1971945408 @default.
• W2059199034 cites W1977305573 @default.
• W2059199034 cites W1982179488 @default.
• W2059199034 cites W1982723873 @default.
• W2059199034 cites W1987243228 @default.
• W2059199034 cites W1988293663 @default.
• W2059199034 cites W1991120368 @default.
• W2059199034 cites W2004649754 @default.
• W2059199034 cites W2007831670 @default.
• W2059199034 cites W2009425569 @default.
• W2059199034 cites W2013157195 @default.
• W2059199034 cites W2017314392 @default.
• W2059199034 cites W2020865074 @default.
• W2059199034 cites W2022886290 @default.
• W2059199034 cites W2028526834 @default.
• W2059199034 cites W2029460942 @default.
• W2059199034 cites W2029696545 @default.
• W2059199034 cites W2030103443 @default.
• W2059199034 cites W2030360754 @default.
• W2059199034 cites W2032687008 @default.
• W2059199034 cites W2036279685 @default.
• W2059199034 cites W2036661104 @default.
• W2059199034 cites W2036712095 @default.
• W2059199034 cites W2037139745 @default.
• W2059199034 cites W2039446733 @default.
• W2059199034 cites W2040601983 @default.
• W2059199034 cites W2046813533 @default.
• W2059199034 cites W2050559057 @default.
• W2059199034 cites W2056802932 @default.
• W2059199034 cites W2057761786 @default.
• W2059199034 cites W2057983131 @default.
• W2059199034 cites W2065106254 @default.
• W2059199034 cites W2073990613 @default.
• W2059199034 cites W2088148914 @default.
• W2059199034 cites W2093138510 @default.
• W2059199034 cites W2097112083 @default.
• W2059199034 cites W2103965396 @default.
• W2059199034 cites W2107057433 @default.
• W2059199034 cites W2113144077 @default.
• W2059199034 cites W2123123877 @default.
• W2059199034 cites W2123433170 @default.
• W2059199034 cites W2123604415 @default.
• W2059199034 cites W2129793174 @default.
• W2059199034 cites W2146673937 @default.
• W2059199034 cites W2149012794 @default.
• W2059199034 cites W2151129590 @default.
• W2059199034 cites W2160821049 @default.
• W2059199034 cites W2161279821 @default.
• W2059199034 cites W2161588304 @default.
• W2059199034 cites W2170468054 @default.
• W2059199034 cites W2219174609 @default.
• W2059199034 cites W2318276210 @default.
• W2059199034 cites W2412804179 @default.
• W2059199034 cites W2419108216 @default.
• W2059199034 cites W28643494 @default.
• W2059199034 cites W3022903699 @default.
• W2059199034 cites W3134490181 @default.
• W2059199034 cites W2096944435 @default.
• W2059199034 doi "https://doi.org/10.1136/bmj.e5182" @default.
• W2059199034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3418219" @default.
• W2059199034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22890029" @default.
• W2059199034 hasPublicationYear "2012" @default.
• W2059199034 type Work @default.
• W2059199034 sameAs 2059199034 @default.
• W2059199034 citedByCount "53" @default.
• W2059199034 countsByYear W20591990342012 @default.
• W2059199034 countsByYear W20591990342013 @default.
• W2059199034 countsByYear W20591990342014 @default.
• W2059199034 countsByYear W20591990342015 @default.
• W2059199034 countsByYear W20591990342016 @default.
• W2059199034 countsByYear W20591990342017 @default.
• W2059199034 countsByYear W20591990342018 @default.
• W2059199034 countsByYear W20591990342019 @default.
• W2059199034 countsByYear W20591990342020 @default.
• W2059199034 countsByYear W20591990342021 @default.
• W2059199034 countsByYear W20591990342022 @default.
• W2059199034 countsByYear W20591990342023 @default.
• W2059199034 crossrefType "journal-article" @default.
• W2059199034 hasAuthorship W2059199034A5011208350 @default.
• W2059199034 hasAuthorship W2059199034A5058932170 @default.

• next